Cairo – Mubasher: Glaxo SmithKline (GSK Egypt) responded to news reports about the acquisition of its subsidiary Amoun Pharmaceutical Industries.
GSK Egypt said that it is not the source of these news reports, according to a bourse disclosure on Tuesday.
Any significant events will be disclosed to the Egyptian Exchange (EGX) in due course, the company said.
During the first nine months of 2020, GSK Egypt reported net profits of EGP 101.41 million, up from EGP 67.03 million in the corresponding period a year earlier.
